[Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].
Okano M, Matsumoto T, Nakamori Y, Ino K, Miyazaki K, Fujieda A, Sugimoto Y, Tawara I, Yamaguchi M, Ohishi K, Miwa H, Masuya M, Wada H, Katayama N.
Okano M, et al. Among authors: ino k.
Rinsho Ketsueki. 2018;59(2):178-181. doi: 10.11406/rinketsu.59.178.
Rinsho Ketsueki. 2018.
PMID: 29515070
Japanese.